TL;DR
This paper presents a novel dynamical model of lipoprotein metabolism that captures the complex interplay between blood transport and cellular regulation. The model reveals a surprising bistability, showing that the system can exist in either a low or high cholesterol state, with implications for understanding diseases like atherosclerosis and the effectiveness of treatments.
What Problem Does This Paper Address?
High levels of low-density lipoproteins (LDL) in the blood are a well-established risk factor for atherosclerosis, a leading cause of death. However, LDL is just one part of a complex metabolic cascade involving various lipoproteins. Previous modeling efforts have often been too simplistic, either focusing on very specific aspects (like fluid dynamics) or using linear compartmental models that lack physiological realism. This paper aims to bridge this gap by developing a low-dimensional, nonlinear dynamical model that integrates both the macroscopic transport of lipoproteins in the blood and the cellular-level regulatory mechanisms, providing a more physiologically relevant framework to study lipoprotein metabolism and its associated diseases.
Methods
The authors developed a dynamical model based on a system of nonlinear differential equations. This model integrates two key aspects:
- Cascading process in the blood stream: This describes how lipoproteins like VLDL are transformed into IDL and then into LDL.
- Cellular level regulatory dynamics: This captures how cells take up LDL via receptors and how intracellular cholesterol levels regulate the synthesis of these receptors.
The model uses a low-dimensional approach, focusing on key variables like VLDL, IDL, LDL, and intracellular cholesterol. They employed bifurcation analysis to study the system's behavior under varying control parameters (liver VLDL secretion rate and reverse cholesterol transport rate) and performed sensitivity analyses to understand the impact of parameter variations on the model's outputs.
Datasets
Not discussed in the paper. The model parameters are derived from literature values and estimates.
Key Insights and Ideas
- Bistability and Hysteresis: The model demonstrates that lipoprotein metabolism can exhibit bistability, meaning the system can settle into either a low or a high cholesterol steady state. This bistability leads to hysteresis, where the system's state depends on its history, making it harder to return to a low cholesterol state once it has transitioned to a high one.
- Intracellular Cholesterol Robustness: A crucial finding is that intracellular cholesterol levels ([IC]) are remarkably robust to variations in most model parameters. This suggests that cells maintain a tightly controlled internal cholesterol environment.
- Plasma Cholesterol Variability: In contrast to intracellular cholesterol, plasma LDL and IDL concentrations are highly sensitive to parameter changes. This implies that plasma cholesterol levels are not tightly regulated and can vary widely, even with viable cellular function.
- Physiological Relevance of Parameters: The model links key parameters to physiological processes and conditions. For example, the VLDL secretion rate (uv) can be influenced by diet and statin medication, while the reverse cholesterol transport rate (dic) is related to HDL function.
- Diagnostic Potential: The model suggests that the dynamical response to time-dependent inputs, particularly oscillations, could serve as a diagnostic tool to distinguish between low and high cholesterol states, potentially by measuring plasma or cellular cholesterol with specific timing.
Key Results
- The model exhibits bistability between low and high cholesterol states, with saddle-node bifurcations occurring at specific values of control parameters (uv and dic).
- Sensitivity analysis shows that plasma LDL concentration ([LDL]) is highly sensitive to most parameters, while intracellular cholesterol ([IC]) is relatively insensitive.
- The characteristic time scales of the system range from hours to days, influencing how the system responds to periodic inputs.
- Forced oscillations in VLDL secretion (uv) can lead to entrainment phenomena, with different responses in IDL, LDL, and IC depending on whether the system is in the low or high cholesterol regime.
- The model can reproduce observed phenomena related to genetic conditions like Familial Hypercholesterolemia, showing how mutations affecting LDL receptors can lead to significantly increased LDL levels.
Limitations and Future Work
- Unphysiologically High Plasma Cholesterol: The model's high cholesterol branch results in plasma cholesterol levels that are unphysiologically high. This suggests that other, unmodeled elimination mechanisms might be at play.
- Crude Approximations: Some approximations, such as the simplified feedback mechanism for LDL receptor synthesis and the lack of explicit time delays, are acknowledged as crude.
- Future Directions:
- Inclusion of HDL: Explicitly modeling HDL as a variable is suggested to improve the description of reverse cholesterol transport.
- Time Delays: Incorporating time delays in receptor-mediated endocytosis and genetic regulatory loops could enhance realism.
- Hepatic vs. Non-hepatic Cells: Differentiating between hepatic and non-hepatic cells would provide a more nuanced understanding, as hepatic cells play a central role and have specific regulatory feedback mechanisms.
- Further Investigation of open questions: The authors suggest that further modeling could shed light on why human plasma cholesterol is so high, the precise effects of statins, and which processes are best targeted to reduce LDL.
Summary updated